Vermont Resources


Vermont offers Medicaid, medicare and medi-cal programs to those residents within the state of Vermont. There is currently an opioid epidemic that is happening throughout the state. With many lawmakers looking to change this, more has to be done to reduce the addictions.

Currently, Vermont has the lowest number of addiction treatment spots of the states. They are seeing a rise in the number of users throughout the state. They need to aim to double the amount of beds and space they have available for those users seeking help. The state universities are looking to increase mental health and addiction programs throughout the entire state for a healthier state. This is a big change that would need a lot of input from others.

There are resources provided below to those that want to learn more about what is available for those with mediciad, medicare or medi-cal insurance coverages in Vermont (not private insurance).

Vermont’s Medicaid Opioid Support in the United States

Table 1:  Medicaid’s Role in Addressing the Opioid Epidemic (as of June 2019)
State Opioid Overdose Death Rate per 100,000 (2017) Number of Opioid Overdose Deaths (2017) Medicaid Coverage of MAT Drugs (2018) IMD Exclusion Waiver for SUD Treatment (2019)
Prescription Opioids Heroin Synthetic Opioids
United States 14.9 14,495 15,482 28,466 M – 41, B – 51,
N – 51
21 Approved,
7 Pending
Alabama 9.0 141 125 198 M, B, N No
Alaska 13.9 47 36 37 M, B, N Approved
Arizona 13.5 349 334 267 M, B, N Pending
Arkansas 6.5 116 15 68 B, N No
California 5.3 973 715 536 M, B, N Approved
Colorado 10.0 254 224 112 M, B, N No
Connecticut 27.7 188 425 686 M, B, N No
Delaware 27.8 64 121 178 M, B, N Pending
District of Columbia 34.7 39 127 182 M, B, N No
Florida 16.3 1,133 707 2,126 M, B, N No
Georgia 9.7 513 263 419 M, B, N No
Hawaii 3.4 33 10 N/A M, B, N No
Idaho 6.2 55 23 22 B, N No
Illinois 17.2 494 1,187 1,251 M, B, N Approved
Indiana 18.8 390 327 649 M, B, N Approved
Iowa 6.9 95 61 92 M, B, N No
Kansas 5.1 74 25 32 B, N Approved
Kentucky 27.9 399 269 780 B, N Approved
Louisiana 9.3 161 162 156 B, N Approved
Maine 29.9 75 76 278 M, B, N No
Maryland 32.2 524 522 1,542 M, B, N Approved
Massachusetts 28.2 254 466 1,649 M, B, N Approved
Michigan 21.2 510 783 1,368 M, B, N Pending
Minnesota 7.8 150 111 184 M, B, N Pending
Mississippi 6.4 89 34 81 M, B, N No
Missouri 16.5 226 299 618 M, B, N No
Montana 3.6 22 N/A N/A M, B, N No
Nebraska 3.1 32 N/A 25 B, N Pending
Nevada 13.3 239 94 66 M, B, N No
New Hampshire 34.0 51 28 374 M, B, N Approved
New Jersey 22.0 424 1,085 1,376 M, B, N Approved
New Mexico 16.7 144 144 75 M, B, N Approved
New York 16.1 821 1,356 2,238 M, B, N No
North Carolina 19.8 573 537 1,285 M, B, N Approved
North Dakota 4.8 18 N/A 12 B, N No
Ohio 39.2 854 1,000 3,523 M, B, N Pending
Oklahoma 10.2 226 61 102 M, B, N No
Oregon 8.1 124 124 85 M, B, N No
Pennsylvania 21.2 564 819 1,982 M, B, N Approved
Rhode Island 26.9 74 14 201 M, B, N Approved
South Carolina 15.5 312 153 404 B, N No
South Dakota 4.0 14 N/A 14 M, B, N No
Tennessee 19.3 592 311 590 B, N Pending
Texas 5.1 535 569 348 M, B, N No
Utah 15.5 290 147 92 M, B, N Approved
Vermont 20.0 27 41 77 M, B, N Approved
Virginia 14.8 336 556 829 M, B, N Approved
Washington 9.6 250 306 143 M, B, N Approved
West Virginia 49.6 279 244 618 M, B, N Approved
Wisconsin 16.9 318 414 466 M, B, N Approved
Wyoming 8.7 30 N/A 17 B, N No
NOTE: Overdose deaths by type of opioid are not mutually exclusive and should not be summed. Synthetic opioid deaths do not include deaths due to methadone. Medication-Assisted Treatment (MAT) drugs are: methadone (M), buprenorphine (B), and naltrexone (N). Naltrexone includes both oral and injectable. An IMD (Institution for Mental Disease) is an inpatient facility with over 16 beds.